SFGP
AMRX icon

Stonebridge Financial Group (Pennsylvania)’s Amneal Pharmaceuticals AMRX Stock Holding History

Stonebridge Financial Group (Pennsylvania)’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$624K Hold
36,054
– – 0.05% 158
2026
Q1 		$448K Hold
36,054
– – 0.04% 175
2025
Q4 		$454K Hold
36,054
– – 0.04% 174
2025
Q3 		$361K Hold
36,054
– – 0.03% 189
2025
Q2 		$292K Hold
36,054
– – 0.03% 196
2025
Q1 		$302K Hold
36,054
– – 0.03% 183
2024
Q4 		$286K Buy
+36,054
New +$302K 0.03% 196

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Stonebridge Financial Group (Pennsylvania)'s AMRX Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 36,054 shares worth $624K. The position accounts for 0.05% of the portfolio, ranked #158.

Stonebridge Financial Group (Pennsylvania) first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 232 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 36,054 shares of Amneal Pharmaceuticals worth $624K as of Q2 2026.
  • Stonebridge Financial Group (Pennsylvania) left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up 0.05% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #158 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 232 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.